iScience (Oct 2022)

Caged-carvedilol as a new tool for visible-light photopharmacology of β-adrenoceptors in native tissues

  • Anna Duran-Corbera,
  • Joan Font,
  • Melissa Faria,
  • Eva Prats,
  • Marta Consegal,
  • Juanlo Catena,
  • Lourdes Muñoz,
  • Demetrio Raldua,
  • Antonio Rodriguez-Sinovas,
  • Amadeu Llebaria,
  • Xavier Rovira

Journal volume & issue
Vol. 25, no. 10
p. 105128

Abstract

Read online

Summary: Adrenoceptors are G protein-coupled receptors involved in a large variety of physiological processes, also under pathological conditions. This is due in large part to their ubiquitous expression in the body exerting numerous essential functions. Therefore, the possibility to control their activity with high spatial and temporal precision would constitute a valuable research tool. In this study, we present a caged version of the approved non-selective β-adrenoceptor antagonist carvedilol, synthesized by alkylation of its secondary amine with a coumarin derivative. Introducing this photo-removable group abolished carvedilol physiological effects in cell cultures, mouse isolated perfused hearts and living zebrafish larvae. Only after visible light application, carvedilol was released and the different physiological systems were pharmacologically modulated in a similar manner as the control drug. This research provides a new photopharmacological tool for a wide range of research applications that may help in the development of future precise therapies.

Keywords